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 Electrocardiography in people living at high altitude of 
Nepal 
Objective 
The main objective of this study was to estimate the prevalence of coronary heart disease (CHD) of high 
altitude populations in Nepal determined by an electrocardiogram (ECG) recordings and a medical 
history. 
Methods 
We carried out a cross-sectional survey of cardiovascular disease and risk factors among people living at 
four different altitude levels, all above 2800 m, in the Mustang and Humla districts of Nepal. 12-lead 
ECGs were recorded on 485 participants. ECG recordings were categorized as definitely abnormal, 
borderline or normal. 
Results 
No participant had Q waves to suggest past Q-wave infarction. Overall 5.6% (95% CI 3.7 to 8.0) of 
participants gave a self-report of CHD. The prevalence of abnormal (or borderline abnormal) ECG was 
19.6% (95% CI 16.1 to 23.4). The main abnormalities were: right axis deviation in 5.4% (95% CI 3.5 to 
7.7), and left ventricular hypertrophy by voltage criteria in 3.5% (95% CI 2.0 to 5.5). ECG abnormalities 
were mainly on the left side of the heart for Mustang participants (Tibetan origin) and on the right side for 
Humla participants (Indo-Aryans). There was a moderate association between the probability of abnormal 
(or borderline abnormal) ECG and altitude when adjusted for potential confounding variables in a 
multivariate logistic model; with an odds ratio for association per 1000 m elevation of altitude of 2.83 
(95% CI 1.07 to 7.45), P=0.03. 
Conclusion  
Electrocardiographic evidence suggests that although high altitude populations do not have a high 
prevalence of CHD, abnormal ECG findings increase by altitude and risk pattern varies by ethnicity.  
 Main Text 
Introduction 
More than 140 million people in the world, comprising 2% of the global population, live permanently at 
high altitude (HA), defined as at greater than 2500 m
1
. The Himalayan mountains of Asia, Andean 
mountains of South America, and Ethiopian summits of northeast Africa are the major geographical 
locations of HA populations
1
.  
The positive and negative effects induced by living at HA, and chronic hypobaric hypoxia, on 
cardiovascular health, are uncertain. Increased angiogenesis and structural vascular changes caused by 
HA may reduce blood pressure (BP) and promote cardio-metabolic efficiency. However,  erythrocytosis 
(from chronically low inspired oxygen concentrations) and pulmonary hypertension (HT) amongst those 
living at HA may be risk factors for adverse cardiovascular events
2
. The largest HA populations, Tibetans 
and Andeans, exhibit different patterns of adaptation and physiological responses to environmental 
hypoxia
3
. Past research shows that genetic factors account for some variance in levels of physiological 
adaptation of HA populations
4
. These factors, in association with different lifestyle practices of HA 
populations, may contribute to research findings that the different HA populations have different risk for 
cardiovascular events. Despite more than five decades of research on cardiovascular health at HA the 
impact of hypoxia on cardiovascular health is still uncertain. 
In Nepal, nearly 2 million people permanently live in mountain areas, representing 7% of the national 
population
5
. Those with Tibetan ancestry are the dominant ethnic HA population in Nepal, for example 
Sherpa, Thakali, Tibetan Gurung, Lama.  
There may be a relationship between usual resident altitude and cardiovascular health in Nepalese HA 
populations because of  hypoxia induced physiological responses. In addition, Tibetan related populations 
are known to have a high prevalence of HT which may raise their risk of coronary heart disease (CHD). 
There has been no research published on prevalence of  CHD among HA populations in Nepal. The main 
purpose of this study was to investigate the prevalence of CHD, determined by a medical history and an 
electrocardiogram (ECG) recording, of people living at different levels of HA in Nepal.  
 Methods 
This was a cross-sectional study. 
Study sample 
Sixteen, out of 75 districts of Nepal, are classified as 'mountain ecological' regions. Two mountainous 
districts (Mustang and Humla) were selected for sampling based on past documentation of geography, 
altitude, population and ethnicity; and the feasibility of conduct for the study. The selected study areas 
were Jomsom (2800 m), Jharkot (3270 m) and Muktinath (3620 m) of the Mustang district, and Simikot 
(2890 m) of the Humla district. In Mustang, the population is predominantly of Tibetan ancestry and that 
of the Humla district is mainly Indo-Aryan. Both districts are close to the border with China and are 
heavily influenced by Tibetan culture. Life expectancy at birth is 64.1 years  in Mustang and 65.0 years in 
Humla. Both are lower than the national figure of 68.8 years
6
. 
As a group Tibetans migrated to high mountains of Nepal some 500 years ago. Tibeto-Burman is their 
native language and they practice Buddhism. Indo-Aryans migrated to Nepal some 2000 years ago, speak 
Nepalese language, and majority of them are Hindu {Eagle, 2000 #4910}. Tibetans and Indo-Aryans are 
distinctive by appearance, language, and name. 
Inclusion criteria for participation were age 30 years and above and the ability to speak and understand 
the Nepalese language. Exclusion criteria were inability or unwillingness to provide written or verbal 
consent, inability to speak or hear properly, and pregnancy. 
Sampling process 
Sampling was carried out in two stages. In the first stage, three study areas of Mustang and one study area 
of Humla were selected on the basis of altitude levels, population density and logistical support to 
undertake the study. In the second stage, a list of households was developed, and a unique number was 
assigned to each of them. Household numbers were randomly selected with the help of the computer 
based randomization technique. All eligible family members of the randomly selected households were 
considered. If none of the household members were eligible or agreed to take part in the study, a 
household in the close proximity was selected. 
The desired sample size within each district was calculated to be around 250 individuals
7
. This gave a 
margin of error for a proportion based on anticipated prevalence of HT of around 25% of plus or minus 
5% after adjusting for the design effect and expected non-response rate of 10%.  
 Data collection procedures 
The questionnaires administration and blood pressure measurements were carried out at the house of the 
selected participants. Practically it was not feasible to undertake blood sample testing, ECG recordings 
and bio-physical measurements in individual houses so a local community hall was used as the 
measurement facility. Participants were requested to come for these measurements at a time  suitable for 
them. Glycated Hemoglobin (HbA1c) and lipid profiles were measured using Cobas b 101 device (Roche 
Diagnostics). A small amount of capillary whole blood was taken by single finger-prick and processed 
into the device. A 12 lead ECG was recorded using a portable Edan SE-600 instrument. Participants were 
requested to remove clothing from the chest, lie supine with arms at their sides and legs uncrossed. Oily, 
sweaty or clammy skin was wiped with alcohol swabs. Qualified female nurses recorded the ECG, 
however, they were standardised on performing ECGs.  
Data was collected during June-August (summer) 2014 in Mustang district and March-May (spring) 2015 
in Humla district. The ambient temperature was between 25 to 31 degree Celsius in Mustang and around 
15 degree Celsius in Humla on most of study days. 
Definitions 
The prevalence of CHD was defined as the presence of pathological Q waves in the ECG (Table 1) or 
self-report of personal history of CHD (previous event of MI or chest pain from heart disease (angina)). 
ECG recordings were categorized as definitely abnormal (e.g. showing evidence of previous myocardial 
infarction (MI)), borderline (e.g. non-specific T-wave inversion) or normal after review by a cardiologist 
(SM) using standard widely accepted criteria. The commonly used Sokolow-Lyon index
8
 and Romhilt-
Estes score
9
 were used for the diagnosis of left ventricular hypertrophy (LVH). The ten-year risk of fatal 
or non-fatal cardiovascular events (MI or stroke) was calculated using a validated risk prediction chart 
designed by the World Health Organization (WHO) and the International Society of Hypertension (ISH) 
for WHO region of South-East Asia, sub region D
10
.  
  
 Table 1: Definition of pathological Q waves  
- Any Q-wave in leads V2-V3 ≥0.02 s or QS complex in leads V2 and V3 
- Q-wave ≥30 ms and ≥0.1 mV deep or QS complex in leads I, II, aVL, aVF or V4-V6 in any 2 leads of a 
contiguous lead grouping (I, aVL, V6; V4 -V6; II, III, and aVF) 
- R-wave ≥40 ms in V1-V2 and R/S ≥1 with a concordant positive T-wave in the absence of a conduction 
defect 
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012). Third universal 
definition of myocardial infarction. Circulation, 126(16), 2020-2035. 
 
Statistical methods 
Simple data description is by mean, standard deviation (SD), frequency counts, and proportions expressed 
as percentages. Comparison of age by altitude level was by the Kruskal-Wallis test and Chi-square test of 
independence was used for the subgroup comparisons by sex and ethnicity. The Clopper-Pearson method 
was used to estimate an exact confidence interval for a single proportion. Logistic regression was used to 
estimate the association between an abnormal (or borderline abnormal) ECG and altitude. Altitude was 
treated as a continuous variable in the multivariate model which also included the variables age, sex, 
systolic blood pressure (SBP), total cholesterol (TC) to high-density lipoprotein-cholesterol (HDL) ratio, 
glycated hemoglobin (HbA1c) and standard drink units (SDUs) of alcohol intake. The strength of the 
associations was considered as strong, moderate, and weak at the significance level of P <0.01, P=0.01 to 
0.05, and P=0.06 to 0.10 respectively. Stata version 12 was used for data analysis. Analysis was  
performed for completed ECG recordings only and thus there were no missing points. 
This study was approved by the ethical review board of Nepal Health Research Council (NHRC) and the 
University of Otago, Human Ethics Committee. 
Results 
A total population of study areas was 2576, of which study participants were selected from 1587 potential 
eligible participants  aged 30 years or more. The study participants comprised a total of 521 HA residents 
at three altitude levels; 2800 m (N=165), 3270 m (N=61) and 3620 m (N=44) of the Mustang district and 
2890 m (N=251) of the Humla district. More than 70% participants in Mustang and Humla were Tibetans 
and Indo-Aryans respectively. Particular ethnic groups amongst Tibetans were: Thakali, Tibetan Gurung 
and Lama; and for Indo-Aryans: Brahmin, Chhetri, and Dalit. Thirty six (6.9%) participants with 
completed questionnaires and BP measurements did not turn up for ECG recordings and bio-chemical 
tests. ECG reports were available for 485 participants. The overall non-response rate was 3.4%. The most 
 common reason for non-participation was unwillingness to provide blood sample due to the cultural belief 
of becoming sick. Participants are described in Table 2. 
Table 2: Description of study participants by altitude level 
  Mustang  Humla  
 2800 m 3270 m 3620 m 2890 m  
 (N=165) (N=61) (N=44) (N=251)  
 Continuous variables Mean (SD) P value 
Age 50.3 (13.7) 55.4 (13.2) 48.3 (12.5) 42.9 (11.0) <0.001 
Average walk time/day (minute) 53.0 (44.8) 95.6 (79.9) 73.2 (53.0) 89.4 (89.6) <0.001 
   
Categorical variables   
 N/165
*
 (%) N/61
*
 (%) N/44
* 
(%) N/251
*
 (%)  
Sex     0.47 
Male 80 (48.5) 29 (47.5) 19 (43.2) 103 (41.0)  
Female 85 (51.5) 32 (52.5) 25 (56.8) 148 (59.0)  
Education     <0.001 
No formal education/illiterate 67 (40.6) 41 (67.2) 29 (65.9) 168 (66.9)  
Less than primary 45 (27.3) 19 (31.1) 6 (13.6) 18 (7.2)  
Primary level completed 25 (15.1) 0 (0) 4 (9.1) 20 (8.0)  
Secondary level completed  28 (17.0) 1 (1.6) 5 (11.4) 45 (17.9)  
Occupation     <0.001 
Govt. or nov-govt. employee 25 (15.1) 1 (1.6) 7 (15.9) 39 (15.5)  
Self-employed 86 (52.1) 6 (9.8) 14 (31.8) 21 (8.4)  
Agriculture/daily waged labour 41 (24.8) 39 (63.9) 21 (47.7) 135 (53.8)  
Unemployed/retired/homemaker 13 (7.9) 15 (24.6) 2 (4.5) 56 (22.3)  
Ethnicity     <0.001 
Tibetan 132(80.0) 58 (95.1) 37 (84.1) 82 (32.7)  
Indo-Aryans 33 (20.0) 3 (4.9) 7 (15.9) 169 (67.3)  
High altitude residence     <0.001 
For lifetime 148 (89.7) 59 (96.7) 38 (86.4) 246 (98.0)  
>10 years 17 (10.3) 2 (3.3) 6 (13.6) 2 (0.8)  
5 to 10 years 0 (0) 0 (0) 0 (0) 3 (1.2)  
Current smoker 17 (10.3) 2 (3.3) 4 (9.1) 97 (38.6) <0.001 
Current drinker 84 (50.9) 39 (63.9) 20 (45.4) 123 (49.0) 0.17 
Hypertension or medication 76 (46.1) 25 (40.9) 24 (54.5) 73 (29.1) <0.001 
Overweight or obesity 81/143 (56.6) 16/60 (26.7) 21 (47.7) 52/251 (20.7) <0.001 
High TC/HDL ratio or medication 34/139 (24.0) 3/54 (5.6) 11/37(29.7) 46/167 (27.5) <0.01 
Diabetes or medication 15/142 (10.6) 2/61 (3.3) 6 (13.6) 6/172 (3.5) 0.01 
*Except where indicated; hypertension, ≥140/90 mmHg; overweight, body mass index ≥25 kg/m2; obesity, body mass index 
≥30 kg/m2; high TC/HDL ratio,  ≥5.0; diabetes, glycated hemoglobin (HbA1c) ≥48 mmol/mol. 
 
 More than a quarter of the study participants at the altitude of 2800 m, 3270 m and 3620 m were aged 60 
years or more. There was evidence of a difference in age at the different altitude levels; Kruskal-Wallis 
test Chi-square (3 DF) 59.1, P <0.01. Women comprised a greater proportion than men at all levels of 
altitude and overall 55.7% of study participants were women but there was no evidence this proportion 
was different by altitude level; Chi-square (3 DF) 2.5, P=0.47. Most of the participants were illiterate or 
had no formal education and reported being born and living at HA for most of their lives. By self-report 
about half of the participants at all altitude stated they were current consumers of alcohol. 
Electrocardiographic analysis 
Arrhythmias: Three participants had isolated ectopic beats on their 12-lead ECGs; one atrial, one 
junctional and one ventricular. Four participants had clear evidence of pre-excitation of the ventricles 
(Wolff-Parkinson-White syndrome). Four participants showed prolonged atrioventricular (AV) nodal 
conduction (first degree AV block) with PR intervals varying between 205 and 286 msec (normal up to 
200msec). One participant had left bundle branch block (LBBB) and six had right bundle branch block 
(RBBB) (three each complete and incomplete). Two participants, a man and a woman, had prolonged QT 
intervals; 470 and 490 msec. 
Morphological abnormalities: Two participants had tall peaked P waves suggesting right atrial 
hypertrophy. Three participants showed extreme axis deviation (arm lead electrode positions all verified 
as correct) with QRS axes between +185
o
 and +237
o
 suggesting possible congenital abnormalities and/or 
pulmonary hypertension. Twenty-six other participants showed right axis deviation (RAD), with QRS 
axes between 92
o
 and 143
o
, of which two had right ventricular hypertrophy (RVH). Four others had left 
axis deviation (LAD), with QRS axes between -34
o
 and -85
o
. No participant had Q waves to suggest past 
Q-wave MI. Thirteen had inverted T waves outside the accepted normal leads (III, aVR, V1), nine of 
these were of doubtful significance as they were in the antero-septal precordial leads V1to V4. Two had 
inverted T waves in inferior leads (II, III and aVF) and two in aVL alone. Seventeen participants met 
Sokolow-Lyon criteria for LVH, with the largest S in V1 or V2 plus the largest R in V5 or V6 greater 
than 3.5mV,  but only one of these met the stricter definition of Romhilt and Estes (six points), three 
others were borderline (four points). Two additional participants had down-sloping ST segments with no 
other cause but suggestive of hypertrophy.  
Overall, none of the participants showed a definite electrocardiographic evidence of CHD. Overall 
27/485, 5.6% (95% confidence interval [CI] 3.7 to 8.0), of the participants gave a self-report of a history 
of CHD confirmed by a medical doctor. The prevalence of CHD according was 17/212 (8.0%) in men and 
10/273 (3.7%) in women, Chi-square (1 DF) 4.3, P=0.04. Altogether 95/485,  19.6% (95% CI 16.1 to 
 23.4), of the participants had an abnormal (or borderline abnormal) ECG. The main abnormalities were: 
RAD in 26/485, 5.4% (95% CI 3.5 to 7.7) and LVH by voltage criteria in 17/485, 3.5% (95% CI  2 to 
5.5). Of 26 participants with RAD, 16 (61.5%) were men and 13 (50%) were from the age-group 30-39 
years. Among 17 participants with LVH, 11 (64.7%) were women, 12 (70.6%) were aged 50 years or 
more, and 11 (70.6%) were hypertensive or on anti-hypertensive treatment. 
Participants resident living in the Mustang district at altitudes of 2800 m, 3270 m and 3620 m mostly had 
abnormalities on the left side of the heart. For Humla participants at 2890 m the main reasons for the 
abnormality were mostly on the right side. For example, Mustang participants had 15/243 (6.2%) ECG 
findings of LVH, LAD, or LBBB; compared to 7/242 (2.9%) Humla participants; Chi-square (1 DF) 3.01, 
P=0.08. In Humla, 21/242 (8.7%) ECG reports had RAD, RBBB, or right atrial hypertrophy; compared to 
13/243 (5.3%) in the Mustang participants; Chi-square (1 DF) 2.06, P=0.15. 
Figure 1 shows the proportions of participants with abnormal (or borderline abnormal) ECG and with 
WHO/ISH 10-year risk of fatal or non-fatal cardiovascular events (MI or stroke) of greater than 10% by 
altitude level. More than one-fourth of the participants at 3270 m (30%) and 3620 m (29.5%) had an 
abnormal (or borderline abnormal) ECG; nearly two-fold higher than those living at 2800 m (15.8%) and 
2890 m (17.4%). Residents at higher altitudes of 3270 m and 3620 m were also more likely to have a 
predicted greater than 10% risk of a fatal or non-fatal major cardiovascular event over the next 10 years.  
 
Figure 1:Proportions of abnormal (or borderline) ECG and WHO/International Society                    
of Hypertension 10-year risk of fatal or non-fatal cardiovascular disease (CVD) events by                    
>10% at each altitude level. 
  
 There was a moderate association between the probability of an abnormal (or borderline abnormal) ECG 
and altitude when adjusted for potential confounding variables in a multivariate logistic model (Table 3). 
There were 99 missing data points in multivariate model and there were no statistically significant 
differences between ECG reports (abnormal or normal) and data status (missing or not missing).  
Table 3: Estimates of the odds ratio for abnormal or borderline ECG by altitude in a multivariate 
logistic model and associations for confounding variables 
Variables and Comparison Odds ratio (95% CI) P value 
Altitude (per 1000 m higher) 2.83 (1.07 to 7.45) 0.03 
Systolic blood pressure (per 10 mmHg higher) 1.25 (1.08 to 1.44) 0.002 
TC to HDL ratio (per unit ratio higher) 0.93 (0.75 to 1.15) 0.49 
HbA1c (per mmol/mol higher) 1.02 (0.99 to 1.05) 0.49 
Smoke tobacco (yes compared to no) 1.69 (0.97 to 2.94) 0.06 
Age (per decade older) 1.14 (0.91 to 1.43) 0.24 
Sex (men compared to women) 1.69 (0.97 to 2.94) 0.06 
 
Discussion 
The prevalence of CHD in this HA population is estimated to be 5.6%. This is based on personal history 
alone as no participant had ECG evidence of past Q-wave MI. The prevalence was higher in men. The 
prevalence of an abnormal (or borderline abnormal) ECG was between 16 and 30% in different HA areas 
sampled for this study from Nepal. After adjusting for the important confounding variables the odds of 
having an abnormal (or borderline abnormal) ECG increased five-fold for every 1000 m increment in 
altitude. This association was particularly strong for men. RAD and LVH were the most common 
abnormalities.  
Our result is strikingly similar to available evidence derived from ECG recordings at low altitude of   
Nepal, China, and Asia; and close to that of rural areas of South Asian countries.  Electrocardiographic 
evidence for CHD at the population level is sparse in Nepal to allow comparisons for our study results. 
Based on ECG and documented medical history, only one population-based sample survey has been 
reported at low altitude of Nepal and amongst men only documented the prevalence of CHD at 5.7%
11
. A 
systematic review of global studies of CHD prevalence based on ECG reports or documented medical 
history in adults and including publications through to 2014 estimated the prevalence of CHD in Asia at 
5.8%, between 5.6% and 5.9% in rural China, between 1.4% to 4.6% in rural areas of India, 3.4% in rural  
area of Bangladesh, and 5.1% in urban Pakistan
12
. Although there have been few population-based studies 
 on CHD in HA populations living at 2500 m or more worldwide, our findings are consistent with the 
majority of hospital-based reports
13 14
 but in contrast to few others
15 16
. The most recent systematic 
analysis of the burden of disease in Chinese provinces showed that the age-standardized mortality rate 
from CHD in Tibet (average altitude of 4500 m from sea level) was significantly lower in men but similar 
in women when compared with those living at lower altitudes
17
. The prevalence of ECG abnormalities in 
this study was also lower when compared with other ECG based studies in HA natives
18-20
. It should be 
noted that studies reporting markedly higher prevalence were conducted in higher levels of altitude 
compared to our study and this may partly explain the differences.  
A review of the English language literature on ECG recordings at different levels of altitude above 2500 
m identified no studies. Thus our finding of significant association between abnormal (or borderline) 
ECG and altitude is difficult to compare with other studies. However, one study did report  increasing 
rates of RAD with increasing levels of altitude in HA setting
21
. In our study, there was a positive 
relationship between SBP and altitude in a multivariate model adjusting for potential confounders. This 
relationship may explain the increased prevalence of an abnormal (or borderline) ECG with increasing 
levels of altitude. For example, more than two-thirds of the participants with LVH were hypertensive or 
on treatment. There are important differences in the prevalence of overweight or obesity, diabetes, and 
walking time by altitude level which may be attributed to urban (2800 m and 3620 m) and rural (2890 m 
and 3270 m) residential settings. The main reason behind low prevalence of current smoker in Tibetan 
dominant study areas is cultural non-preference to tobacco smoking. 
The low prevalence of CHD in the study reported here may have several possible explanations. The 
reasons proposed for possible cardioprotection in HA residents includes activation of a transcriptor-
modulator hypoxia inducible factor (HIF-1) which induces the expression of multiple genes with 
cardioprotective properties
22
. High levels of vitamin D due to an exponential increase in ultraviolet B 
(UVB) light at HA
23
, improvement in coronary vasculature through increased number of branches and 
peripheral vessels
24
, increased levels of physical fitness and low level of air pollution
25
 could  also 
provide cardioprotection. A 'healthy individuals effect' is an alternative explanation to these findings from 
non-experimental studies of illness at HA because sick people often migrate to LA for better treatment
26
. 
It is plausible that the CHD related risk pattern at HA is also ethnicity specific due to varying degree of 
adaptation, physiological response, lifestyle and genetic factors. Contrasting cardiopulmonary responses 
to HA exposure among the largest HA populations; Tibetans, Andeans, and Aymaras have been 
documented
27
. The finding in this study that abnormal or borderline abnormal ECG recordings on the left 
side of the heart were more prevalent among those of the Tibetan ethnicity (Mustang district) whereas 
 right sided abnormalities were more frequent in Humla district with majority of Indo-Aryan participants, 
may reflect this phenomena. The ECG abnormalities suggesting right heart abnormalities may reflect 
increased pulmonary vascular resistance; well reported at greater level among HA dwellers less adapted 
with hypoxia such as Andeans or North Americans
19 28
 but at lower level in those with high degree of 
adaptation such as Tibetans
29
. The high prevalence of RAD in our study, particularly in Humla 
participants, also suggests a possible early indication of pulmonary HT or RVH. A previous report 
suggested RAD could be up to four times more prevalent at HA compared to sea level presumably 
correlating with differences in pulmonary artery pressure
30
. 
As far as we are aware, this is the only study which has provided detailed information on CHD health and 
comprehensively assessed cardiovascular risk among HA natives in Nepal. Limitations of this study 
included possible bias due to the purposive selection of the study areas on the basis of altitude levels, 
population density and logistical convenience. Validity of the self-report of CHD is also questionable 
particularly due to the poor literacy rate of the participants. Reported prevalence might not reflect true 
incidence due to the 'healthy individual effect'.  Difference in temperature in Mustang and Humla districts 
during data collection period may confound observed association. There were possible confounding 
variables which are commonly relevant for CHD. There might be other unmeasured confounding 
variables particularly related to the HA populations. 
In conclusion, our findings based on personal history and ECG recordings suggest that HA populations of 
this study area had a prevalence of CHD comparable to that seen in low altitude populations. However, 
we demonstrated moderate evidence of an association between participants having an abnormal (or 
borderline abnormal) ECG and altitude in our HA populations in Nepal. The risk pattern may vary by 
ethnicity; increased pulmonary vasoconstriction reflected by RAD in Indo-Aryans (Humla district) and 
HT induced LVH in participants of Mustang with Tibetan ancestry. Clinicians should be aware of 
differential effects of HA living on cardiovascular health by ethnicity. More useful epidemiology may 
depend on better information infrastructure in the relevant population (e.g. improvement in registration of 
births, deaths and marriages). Directly comparable data compilation from residents living at low and high 
altitudes would add clarity to attribution of health status to altitude per se.  
 1. What is already known about this subject? 
The balance of risks and benefits for cardiovascular health in permanent residents of high altitude is 
uncertain. Different patterns of adaptation and physiological responses against hypobaric hypoxia as well 
as different lifestyle practices of high altitude populations probably contribute.   
2. What does this study add? 
This is first ECG-based study examining evidence of coronary heart disease in high altitude populations 
of Nepal. The prevalence of coronary heart disease in high altitude populations may be comparable with 
those from low altitude residents. However, ECG abnormalities may increase by altitude and the risk 
pattern may vary by ethnicity; mostly on the right side of the heart in Indo-Aryans and on the left side in 
Tibetans. 
3. How might this impact on clinical practice? 
Clinicians should be aware of differential effects of high altitude living on cardiovascular health by 
ethnicity. 
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